Articles by author - Tomas Stulc

The effect of simvastatin and fenofibrate on the expression of leukocyte adhesion molecules and lipopolysaccharide receptor CD14 in type 2 diabetes mellitus.

Stulc T, Ceska R, Marinov I, Skrha J.

Journal Article 2012; 33(Suppl 2): 73-77 PubMed PMID: 23183514  Keywords:  Adult, Antigens, CD11a:metabolism, Antigens, CD14:metabolism, Antigens, CD18:metabolism, Cross-Over Studies, Diabetes Mellitus, Type 2:drug therapy, Dyslipidemias:drug therapy, Female, Fenofibrate:administration & dosage, Humans, Hypolipidemic Agents:admi.    Citation

BACKGROUND: Mixed hyperlipidemia is often associated with type 2 diabetes mellitus and contributes to atherosclerosis progression in diabe.....

Read abstract  Full text PDF

Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus.

Vrablík M, Dobiásová M, Stulc T, Kasalová Z, Dolezalová R, Prázný M, Fait T, Ceska R.

Controlled Clinical Trial 2008; 29(1): 146-150 PubMed PMID: 18283261  Keywords:  Aged, Biomarkers:blood, Cardiovascular Diseases:blood, Cholesterol, LDL:blood, Diabetes Mellitus, Type 2:blood, Female, Fenofibrate:adverse effects, Humans, Lipoproteins:blood, Male, Middle Aged, Peroxisome Proliferator-Activated Receptors:agonists, Phosp.    Citation

BACKGROUND: Particle size distribution in both HDL and LDL is reflected in the fractional esterification rate of cholesterol by lecithin c.....

Read abstract  Full text PDF